Institute of Human Virology Annual Meeting 2004

2004年人类病毒学研究所年会

• 批准号: 6837997
• 负责人: ROBERT C GALLO
• 金额: $ 9.65万
• 依托单位: UNIVERSITY OF MD BIOTECHNOLOGY INSTITUTE
• 依托单位国家: 美国
• 财政年份: 1999
• 资助国家: 美国
• 起止时间: 1999-08-18 至 2005-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6837997
• 关键词: AIDS; AIDS related neoplasm /cancer; AIDS therapy; HIV infections; antiAIDS agent; disease reservoirs; genetic susceptibility; hepatitis; human immunodeficiency virus 1; immune response; medical complication; meeting /conference /symposium; pathologic process; travel; virus characteristic

DESCRIPTION (provided by applicant): For eight years the International Meeting of the Institute of Human Virology (Meeting) has provided a forum for dedicated scientists in the fields of virology, most specifically HIV/AIDS and cancer biology to present new data and exchange ideas and views. The Meeting serves as a unique conference with the following aims: 1. To disseminate the most current research findings within the selected program topics; 2. To critically assess the impact of new findings on future directions for research; 3. To provide a forum for discussion of current and emerging issues; 4. To identify, support, and build the next generation AIDS researcher; 5. To increase participation by women ethnic/racial minorities, and other individuals who have been traditionally under represented in science, yet over represented in the populations impacted most by the disease and to increase participation by individuals from the developing world. The Institute of Human Virology (IHV), with the financial support requested in this application, will accomplish these aims: a) by attracting world renown senior scientists as presenters and participants; b) by carefully organizing each dedicated conference session with theoretically divergent perspectives and ethnically diverse participants; c) by enriching the scientific sessions with an open schedule to foster dialog and interaction between and among investigators; d) by reaching out to and promoting the participation of young investigators in poster sessions and scholarship initiatives; and e) by ensuring that conference results are shared with the broader scientific community through publication of all speaker and poster abstracts. The Meeting is further strengthened by a strictly enforced press policy, one that protects data presented at the Meeting for future peer-reviewed publication. This policy prohibits the members of the press from disclosing any information presented at the Annual Meeting without the permission of the presenter. An estimated 900 scientists and clinicians from around the world are expected to participate in this five-day meeting scheduled for October 31- November 4, 2004 at the Hyatt Regency Baltimore. The Meeting for 2004 will offer a combination of single track and dual track lectures. The incorporation of dual track sessions is a result of feedback from our participants who like some of the more specialized sessions that may not be of interest to the entire group but may be hot topics at more general meetings they attend including topics like HTLV. This change also allows for more time to be set aside for oral presentations selected from a call for abstracts. Each conference session opens with a senior scientist's overview presentation on the current base of knowledge in the topic of discussion. This overview provides a basis for evaluation of the data presented by a panel of speakers, each sharing the results of their work. The Annual Meeting Program Committee, responsible for the program content, is encouraged to invite speakers with differing perspectives to stimulate open discussion. Posters are displayed throughout the meeting. One evening is set aside for a reception in the poster area to encourage attendance and interaction. Evening social events are provided to encourage participants to meet with current and potential collaborators, and to talk with presenters. The Annual Meeting Scholarship Initiative provides funds to ensure the participation of promising women, ethnic and racial minorities, and other individuals who have been traditionally underrepresented in science as well as participants from the developing world.

描述(由申请人提供)：八年来，人类病毒学研究所国际会议(会议)为病毒学领域，特别是艾滋病毒/艾滋病和癌症生物学领域的敬业科学家提供了一个论坛，介绍新的数据并交流想法和观点。这次会议是一次独特的会议，目的如下：1.在选定的计划主题内传播最新的研究成果；2.批判性地评估新发现对未来研究方向的影响；3.为当前和新出现的问题提供讨论的论坛；4.确定、支持和建设下一代艾滋病研究人员；5.增加妇女、少数民族和其他个人的参与，这些人传统上在科学界的代表性不足，但在受该疾病影响最大的人群中代表过多，并增加来自发展中国家的个人的参与。人类病毒学研究所(IHV)在本申请所要求的资金支持下，将实现这些目标：a)通过吸引世界知名资深科学家作为演讲者和参与者；b)精心组织每一次有理论上不同观点和不同种族参与者的专门会议；c)通过开放的日程安排丰富科学会议，以促进研究人员之间的对话和互动；d)接触并促进青年研究人员参与招贴会议和学术活动；e)通过出版所有发言者和招贴摘要，确保与更广泛的科学界分享会议成果。严格执行的新闻政策进一步加强了会议，保护在会议上提交的数据，以供未来同行审查的出版。这项政策禁止媒体成员在未经主讲人许可的情况下披露在年会上提交的任何信息。预计将有来自世界各地的900名科学家和临床医生参加定于2004年10月31日至11月4日在巴尔的摩凯悦酒店举行的为期5天的会议。 2004年的会议将提供单轨和双轨相结合的讲座。双轨课程的纳入是我们参与者反馈的结果，他们喜欢一些更专业的课程，这些课程可能不会引起整个团队的兴趣，但可能是他们参加的更多大会上的热门话题，包括HTLV等话题。这一变化还允许留出更多的时间用于从摘要征集中选择的口头陈述。每一次会议以一位资深科学家就讨论主题的当前知识基础所作的概述为开场白。这一概览为评价发言者小组提出的数据提供了基础，每个发言者都分享了自己的工作成果。鼓励负责节目内容的年会计划委员会邀请不同观点的演讲者，以激发公开讨论。海报在整个会议期间都会张贴。留出一晚在海报区域举行招待会，以鼓励参观者和互动。提供晚间社交活动，鼓励参与者与当前和潜在的合作者见面，并与演讲者交谈。年度会议奖学金倡议提供资金，以确保有前途的妇女、少数族裔和少数族裔、传统上在科学界代表性不足的其他个人以及来自发展中国家的参与者参加会议。